Sunshine Biopharma Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -5,875.6% | -5,875.6% | -564.6% |
| FY2022 | -123.7% | -123.7% | -91.5% |
| FY2023 | -21.2% | -21.2% | -16.5% |
| FY2024 | -21.8% | -21.8% | -16.8% |
| FY2025 | -25.9% | -25.9% | -19.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -5,875.6% | -5,875.6% | -564.6% |
| FY2022 | -123.7% | -123.7% | -91.5% |
| FY2023 | -21.2% | -21.2% | -16.5% |
| FY2024 | -21.8% | -21.8% | -16.8% |
| FY2025 | -25.9% | -25.9% | -19.9% |